Simplify your online presence. Elevate your brand.

Biocon Welcomes Indias Duty Exemptions On Cancer Chronic Disease Drugs

Biocon Welcomes India S Duty Exemptions On Cancer Disease Drugs
Biocon Welcomes India S Duty Exemptions On Cancer Disease Drugs

Biocon Welcomes India S Duty Exemptions On Cancer Disease Drugs Peter bains, group ceo of biocon, talks about india's budget, and the impact of its plans to cut or remove duties on life saving medicinal drugs. he also talks about the biopharma company's. Kiran mazumdar shaw, chairperson of biocon, has urged the government to remove tax on medicines used to treat cancer, chronic illnesses, and rare diseases in budget.

Biocon Launching A New Cancer Drug In India Pdf Clinical Trial
Biocon Launching A New Cancer Drug In India Pdf Clinical Trial

Biocon Launching A New Cancer Drug In India Pdf Clinical Trial Peter bains, group ceo of biocon, talks about india's budget, and the impact of its plans to cut or remove duties on life saving medicinal drugs. he also talks about the biopharma company's product pipeline in its advanced markets including us, uk and europe. Peter bains, group ceo of biocon, talks about india's budget, and the impact of its plans to cut or remove duties on life saving medicinal drugs. Biocon ltd founder and chairperson kiran mazumdar shaw has urged the government to make medicines for cancer, chronic illnesses, and rare diseases tax free, ahead of india’s 1 february budget announcement. In a significant move to enhance affordability and accessibility of life saving drugs, india's leading biopharmaceutical company, biocon, has urged the indian government to exempt cancer and rare disease drugs from tax in the upcoming union budget 2025.

Biocon Launching A New Cancer Drug In India Pdf
Biocon Launching A New Cancer Drug In India Pdf

Biocon Launching A New Cancer Drug In India Pdf Biocon ltd founder and chairperson kiran mazumdar shaw has urged the government to make medicines for cancer, chronic illnesses, and rare diseases tax free, ahead of india’s 1 february budget announcement. In a significant move to enhance affordability and accessibility of life saving drugs, india's leading biopharmaceutical company, biocon, has urged the indian government to exempt cancer and rare disease drugs from tax in the upcoming union budget 2025. India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major drugmaker biocon ltd said ahead of prime minister narendra modi's budget announcement, expected next month. The cost of chemotherapy and other related therapies has significantly dropped because basic customs duty (bcd) has been fully waived for 17 cancer drugs. medicines for 7 rare diseases and specialised medical foods are now duty exempt. On friday, drugs used for treating chronic diseases such as diabetes and cancer should be exempted from tax. We applaud the exemption of 36 life saving drugs from basic customs duty (bcd) and the addition of six more medicines under concessional duty will provide significant relief to patients, particularly those suffering from cancer, rare diseases, and other chronic conditions.

Chronic Disease Medication India S Biocon Urges Government To Exempt
Chronic Disease Medication India S Biocon Urges Government To Exempt

Chronic Disease Medication India S Biocon Urges Government To Exempt India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major drugmaker biocon ltd said ahead of prime minister narendra modi's budget announcement, expected next month. The cost of chemotherapy and other related therapies has significantly dropped because basic customs duty (bcd) has been fully waived for 17 cancer drugs. medicines for 7 rare diseases and specialised medical foods are now duty exempt. On friday, drugs used for treating chronic diseases such as diabetes and cancer should be exempted from tax. We applaud the exemption of 36 life saving drugs from basic customs duty (bcd) and the addition of six more medicines under concessional duty will provide significant relief to patients, particularly those suffering from cancer, rare diseases, and other chronic conditions.

Biocon Nudges Government To Exempt Cancer Rare Disease Drugs From Tax
Biocon Nudges Government To Exempt Cancer Rare Disease Drugs From Tax

Biocon Nudges Government To Exempt Cancer Rare Disease Drugs From Tax On friday, drugs used for treating chronic diseases such as diabetes and cancer should be exempted from tax. We applaud the exemption of 36 life saving drugs from basic customs duty (bcd) and the addition of six more medicines under concessional duty will provide significant relief to patients, particularly those suffering from cancer, rare diseases, and other chronic conditions.

Comments are closed.